# Humidity-Guarded Oxygen Hub

**Author: jayis1**

**Status: TRL 2 concept, not a certified medical device or clinical-use instruction.**

## Problem

Hypoxaemia in childhood pneumonia can raise the risk of death substantially, while small hospitals often lack dependable oxygen and the means to maintain concentrators.[1] Oxygen supply also serves adults and newborns, but their delivery settings and flow requirements differ. Grid outages, humid intake air, blocked filters, exhausted sieve beds, and missing spare parts can turn an apparently running concentrator into an inadequate oxygen source. This proposal serves staffed rural clinics, not unattended home treatment.

## Solution

A repairable, clinic-scale hub combines a **continuous-flow pressure-swing-adsorption (PSA) concentrator**, a locally replaceable prefilter/dryer and sealed zeolite sieve cassette, a battery-backed DC power bus, and an independent oxygen-concentration monitor. A small oil-free compressor alternately pressurizes two zeolite beds: the zeolite preferentially retains nitrogen, while oxygen-enriched gas goes through a buffer vessel, regulator and calibrated flowmeter. Nitrogen is released during bed depressurization. This is established concentrator physics, not a new way to make oxygen.[3]

The proposed improvement is a **serviceable humidity-and-quality boundary**: measure intake/bed-inlet humidity and outlet oxygen concentration independently; flag drying or sieve degradation before quality falls; and make a keyed, tool-light cartridge replacement possible without opening the patient gas path. On loss of power, low purity, blocked outlet or failed sensing, sound a locally powered alarm and mark the concentrator outlet **unqualified**. A trained clinician must transfer to an independently checked reserve cylinder or another qualified source under the clinic's protocol. An alarm or valve cannot itself guarantee oxygen continuity. No automated prescription, pulse-oximeter feedback dosing, radio, cloud service or patient records are built in.

**Unverified design gates:** continuous **5 L/min** at **90–96% oxygen by volume** across a specified test envelope including **40 °C, 95% RH and 2,000 m altitude**; electrical input **≤350 W at rated flow**; a **2 kWh usable LiFePO4 battery** supporting **at least four hours** at rated load including conversion losses; an optional **1 kWp PV array** to offset daytime demand where insolation allows. A four-hour, 350 W load uses 1.4 kWh before conversion and auxiliary losses, so 2 kWh usable is a budget, not a guaranteed reserve after battery ageing. WHO guidance reports typical facility concentrators at 280–600 W and specifies testing in hot, humid, high-altitude conditions; these proposed gates require independent testing.[3] The PV panel alone does not make the unit continuously off-grid: cloudy days require charging infrastructure or reserve oxygen.

## Key Innovation

**Condition-based, physically replaceable sieve service coupled to independent gas-quality release** is the research contribution. Existing WHO/UNICEF specifications already describe PSA, filters, purity alarms and maintenance; none of these parts alone is claimed as novel.[2][4] The question is whether a sealed, locally serviceable dryer/sieve module plus humidity trending can extend reliable operation and shorten repair time *without* compromising medical-gas cleanliness, oxygen concentration, flow or cost. A controlled comparison against a maintained, certified 5 L/min concentrator with the same backup supply is required. A commercially available device that already meets these service and reliability gates would defeat the novelty and economic case.

This is distinct from the repository's [photoacoustic anemia screener](../photoacoustic-anemia-screener/) (triage rather than gas supply), [thermostable vaccine microarray patch](../thermostable-vaccine-microarray-patch/) (immunization), and [radiative-adsorption refrigerator](../radiative-adsorption-refrigerator/) (cold storage). It does not claim to replace any of those technologies.

## Target Cost

**Planning allocation, not supplier quotations, at 10,000 units/year in a 2038 manufacturing scenario:** US$850 for compressor, valves, zeolite beds, reservoir and controls; US$650 for 2 kWh usable LiFePO4 battery with management and protected DC conversion; US$450 for optional 1 kWp PV modules and controller; US$200 for independent purity/humidity monitoring and alarms; US$300 for assembly, training and initial installation. **US$2,450 total with PV** under those assumptions, excluding taxes, freight, site wiring, reserve cylinder and refill logistics, patient tubing, medical certification and clinic labour. Without a qualifying site or stocked backup oxygen, the system is not deployable. Budget a separately verified annual service contract and replacement parts; no zero-maintenance claim is made. Clinics must compare total cost per *qualified litre delivered*, including interruptions, against certified existing concentrators and cylinders.

## Impact

A planning scenario of **10,000 hubs × 5 L/min × 8 qualified operating hours/day** gives capacity for **24 million litres/day** at rated flow, not a patient count or a predicted health outcome. Actual qualified output, unmet oxygen-hours, repair time and cylinder fallback use must be logged during a prospective clinic trial. The benefit would be fewer interruptions *only if* matched field sites show improvement over a properly maintained conventional concentrator; patient outcomes depend on timely clinical assessment, appropriate flow and monitoring, and reliable backup oxygen.[1]

## Safety, limits and validation

- Oxygen-enriched atmospheres increase fire risk. Keep flame, oil and grease away; test leakage, overpressure relief, flow accuracy, electrical isolation, heat, electromagnetic compatibility, cleaning, intake contamination, ozone/particulates and oxygen-compatible wetted materials against applicable medical-device standards. No oxygen storage at unsafe pressures is proposed.
- Humidity sensing is an early-warning hypothesis, **not proof of oxygen purity**. Independently verify outlet concentration at every rated flow and after ageing; a stale, failed or disagreeing sensor is a service fault, not a pass. Reject cartridges with damaged seals, dust shedding, moisture intrusion or unverified provenance.
- Do not interrupt a patient's only oxygen supply simply because an alarm trips: implement a supervised clinical transfer to a separate certified reserve, with sufficient cylinder inventory and training. Test alarms and switchover under simultaneous blackout, high humidity and exhausted battery. No unattended switch to an unverified source.
- Run bench trials at controlled heat, humidity, altitude, inlet dust and flow; then a preregistered, site-matched clinic trial comparing **qualified oxygen-hours**, concentration and flow excursions, mean time to repair, maintenance cost, and adverse events with standard equipment. Stop if quality, safety or economic gates are missed. Device certification and local regulatory approval precede patient use.
- **10–20-year feasibility path:** bench-test cartridge sealing and regeneration economics; conduct accelerated bed and battery ageing; validate independent gas monitoring and service procedures; seek regulatory review; then undertake comparative field trials and regional spare-parts manufacturing. This is an integration and reliability research program, not a claim of a working prototype.

## Sources

[1] https://www.who.int/publications/i/item/9789241549554
[2] https://www.who.int/publications/i/item/9789241516914
[3] https://iris.who.int/server/api/core/bitstreams/6a4ae877-d02b-4db5-80d2-751090650f69/content
[4] https://www.unicef.org/supply/media/2916/file/oxygen-concentrator-TPP.pdf
